104 related articles for article (PubMed ID: 24218026)
21. Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression.
Foda AAM; Atia T; Sakr HI; Abd Elaziz Ahmed Elnaghi K; Abdelhay WM; Enan ET
J Evid Based Integr Med; 2023; 28():2515690X231198315. PubMed ID: 37654084
[No Abstract] [Full Text] [Related]
22. EBV-negative Fibrin-Associated Large B-Cell Lymphoma Arising in Thyroid Hyperplastic Nodule: Report of a Case and Literature Review.
Ho TW; Cheuk W; Chan JKC
Int J Surg Pathol; 2023 Oct; 31(7):1420-1425. PubMed ID: 36843554
[TBL] [Abstract][Full Text] [Related]
23. CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.
Wang WT; Xing TY; Du KX; Hua W; Guo JR; Duan ZW; Wu YF; Wu JZ; Li Y; Yin H; Shen HR; Wang L; Li JY; Liang JH; Xu W
Cancer Lett; 2024 Feb; 583():216616. PubMed ID: 38211650
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and genetic landscape of plasmablastic lymphoma in Taiwan.
Chen BJ; Hsieh TH; Yuan CT; Wang RC; Yang CF; Chuang WY; Su YZ; Ho CH; Lin CH; Chuang SS
Pathol Res Pract; 2024 Jan; 253():155059. PubMed ID: 38160484
[TBL] [Abstract][Full Text] [Related]
25. EBV-Positive Intravascular Large B-Cell Lymphoma of the Small Intestine: A Case Report and Literature Review.
Pan C; Ma X; Yao Y; Wang C
Int J Surg Pathol; 2024 May; 32(3):586-593. PubMed ID: 37431259
[TBL] [Abstract][Full Text] [Related]
26. Indolent EBV-positive T-cell lymphoma of the gastrointestinal tract with metachronous lesions involved by different neoplastic clones.
Chuang SS; Tzioni MM; Chen Z; Feng YH; Shih CW; Casà C; Du MQ
Pathology; 2024 Apr; 56(3):431-434. PubMed ID: 37914596
[No Abstract] [Full Text] [Related]
27. EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies.
Williams M; Ariza ME
Cancers (Basel); 2018 May; 10(5):. PubMed ID: 29723986
[TBL] [Abstract][Full Text] [Related]
28. Gastric cancer molecular classification based on immunohistochemistry and in-situ hybridisation and mortality.
Eskuri M; Birkman EM; Kauppila JH
Histopathology; 2024 May; ():. PubMed ID: 38715404
[TBL] [Abstract][Full Text] [Related]
29. Targeted mutational profiling of Epstein Barr virus-positive mucocutaneous ulcer: Implications for differential diagnosis with EBV-positive diffuse large B-cell lymphoma.
Volaric AK; Kumar J; Nicholas V; Saleem A; Fernandez-Pol S; Suarez CJ; Natkunam Y
Ann Diagn Pathol; 2024 May; 73():152344. PubMed ID: 38820910
[TBL] [Abstract][Full Text] [Related]
30. Role of Epstein-Barr Virus in Breast Cancer: Correlation with Clinical Outcome and Survival Analysis.
Hsu YC; Tsai MH; Wu G; Liu CL; Chang YC; Lam HB; Su PY; Lung CF; Yang PS
J Cancer; 2024; 15(8):2403-2411. PubMed ID: 38495506
[No Abstract] [Full Text] [Related]
31. Multiple cutaneous ulcers revealing a primary cutaneous Epstein-Barr virus-positive diffuse large B-cell lymphoma.
Tedbirt B; Dubois S; Cellier L; Carvalho P; Stamatoullas A; Courville P; Deschamps-Huvier A; Etancelin P; Deniel A; Tilly H; Jardin F; Joly P; Camus V
Clin Case Rep; 2020 Dec; 8(12):2578-2582. PubMed ID: 33363783
[TBL] [Abstract][Full Text] [Related]
32. Primary age-related EBV-associated effusion-based lymphoma successfully treated with rituximab and thoracentesis.
Kuhlman JJ; Alhaj Moustafa M; Tun AJ; Menke DM; Tun HW; Jiang L
Clin Case Rep; 2021 May; 9(5):e03971. PubMed ID: 34094552
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
Uccini S; Al-Jadiry MF; Scarpino S; Ferraro D; Alsaadawi AR; Al-Darraji AF; Moleti ML; Testi AM; Al-Hadad SA; Ruco L
Hum Pathol; 2015 May; 46(5):716-24. PubMed ID: 25704629
[TBL] [Abstract][Full Text] [Related]
34. Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma.
Chen NC; Chang H; Kao HW; Ou CW; Kuo MC; Wang PN; Lin TL; Wu JH; Hung YS; Su YJ; Ong YC; Shih HJ
Clin Exp Med; 2023 Nov; 23(7):3759-3766. PubMed ID: 37086332
[TBL] [Abstract][Full Text] [Related]
35. Advances in the Pathogenesis of EBV-Associated Diffuse Large B Cell Lymphoma.
Chabay P
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072731
[TBL] [Abstract][Full Text] [Related]
36. The Incidence of Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: A Systematic Review and Meta-Analysis.
Hwang J; Suh CH; Won Kim K; Kim HS; Armand P; Huang RY; Guenette JP
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917961
[TBL] [Abstract][Full Text] [Related]
37. Chronic active Epstein-Barr virus infection involving gastrointestinal tract mimicking inflammatory bowel disease.
Xu W; Jiang X; Chen J; Mao Q; Zhao X; Sun X; Zhong L; Rong L
BMC Gastroenterol; 2020 Aug; 20(1):257. PubMed ID: 32758149
[TBL] [Abstract][Full Text] [Related]
38. IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma.
Wang Y; Wang C; Cai X; Mou C; Cui X; Zhang Y; Ge F; Dong H; Hao Y; Cai L; Wu S; Feng C; Chen J; Li J; Xu W; Fan L; Xie W; Tong Y; Gu HF; Wu L
Sci Rep; 2020 Jul; 10(1):12326. PubMed ID: 32704112
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and prognostic significance of EBER positivity in diffuse large B-cell lymphoma: A meta-analysis.
Gao X; Li J; Wang Y; Liu S; Yue B
PLoS One; 2018; 13(6):e0199398. PubMed ID: 29920566
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic response against Epstein Barr virus coexists with diffuse large B-cell lymphoma tolerogenic microenvironment: clinical features and survival impact.
Cohen M; Vistarop AG; Huaman F; Narbaitz M; Metrebian F; De Matteo E; Preciado MV; Chabay PA
Sci Rep; 2017 Sep; 7(1):10813. PubMed ID: 28883511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
